These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Gene expression and in situ localization of ADAM17 during skin wound healing. Kawaguchi M; Suzuki T Int J Dermatol; 2014 Mar; 53(3):e229-31. PubMed ID: 23834487 [No Abstract] [Full Text] [Related]
10. Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells. Tsukamoto H; Tanida S; Ozeki K; Ebi M; Mizoshita T; Shimura T; Mori Y; Kataoka H; Kamiya T; Fukuda S; Higashiyama S; Joh T Inflamm Bowel Dis; 2013 Jun; 19(7):1365-73. PubMed ID: 23702712 [TBL] [Abstract][Full Text] [Related]
11. Identification of ADAM10 and ADAM17 with potential roles in the spermatogenesis of the Chinese mitten crab, Eriocheir sinensis. Li Q; Xie J; He L; Wang Y; Duan Z; Yang H; Wang Q Gene; 2015 May; 562(1):117-27. PubMed ID: 25703701 [TBL] [Abstract][Full Text] [Related]
12. ADAM17 at the interface between inflammation and autoimmunity. Lisi S; D'Amore M; Sisto M Immunol Lett; 2014 Nov; 162(1 Pt A):159-69. PubMed ID: 25171914 [TBL] [Abstract][Full Text] [Related]
13. MiR-152 reduces human umbilical vein endothelial cell proliferation and migration by targeting ADAM17. Wu Y; Huang A; Li T; Su X; Ding H; Li H; Qin X; Hou L; Zhao Q; Ge X; Fang T; Wang R; Gao C; Li J; Shao N FEBS Lett; 2014 Jun; 588(12):2063-9. PubMed ID: 24813629 [TBL] [Abstract][Full Text] [Related]
14. Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma. Liu Y; Wu C; Wang Y; Wen S; Wang J; Chen Z; He Q; Feng D Acta Biochim Biophys Sin (Shanghai); 2014 Aug; 46(8):720-2. PubMed ID: 24969373 [No Abstract] [Full Text] [Related]
15. Expression profile of ADAM10 and ADAM17 in allergic rhinitis. Chueh HW; Park SK; Hur DY; Bae WY Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527 [TBL] [Abstract][Full Text] [Related]
16. No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. Franke A; Ruether A; Wedemeyer N; Karlsen TH; Nebel A; Schreiber S Gut; 2006 Nov; 55(11):1679-80. PubMed ID: 17047129 [No Abstract] [Full Text] [Related]
17. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418 [TBL] [Abstract][Full Text] [Related]
18. The disintegrin domain of ADAM17 antagonises fibroblast‑carcinoma cell interactions. Trad A; Riese M; Shomali M; Hedeman N; Effenberger T; Grötzinger J; Lorenzen I Int J Oncol; 2013 May; 42(5):1793-800. PubMed ID: 23545805 [TBL] [Abstract][Full Text] [Related]
19. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569 [TBL] [Abstract][Full Text] [Related]
20. Effects of pro-inflammatory cytokines on the production of soluble fractalkine and ADAM17 by HepG2 cells. Turner SL; Mangnall D; Bird NC; Blair-Zajdel ME; Bunning RA J Gastrointestin Liver Dis; 2010 Sep; 19(3):265-71. PubMed ID: 20922190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]